The Government of Nigeria, with support from the World Health Organization (WHO), Gavi, the Vaccine Alliance and UNICEF will vaccinate 26.2 million people during the second phase of its biggest-ever yellow fever campaign .
The step of the campaign, which is funded by Gavi will run from 22 November to 1 December 2018 and will target children and adults in Plateau, Sokoto, Kebbi, Niger and Borno states as well as the Federal Capital Territory.
The Director of Special duties , National Primary Health Care Development agency, Dr Joseph Oteri said the vaccination will be for people within 9 months to 44 years age.
“The vaccination will be for people within 9 months to 44 years cohort, parents are advised to avail themselves and their children to partake in the vaccination; The vaccine is free, safe and effective,”
“Yellow fever is caused by a virus spread through the bite of infected mosquitos. Some patients can develop serious symptoms, including high fever and jaundice (yellowing of the skin and eyes), but the disease can be easily prevented by a vaccine that provides immunity for life.”
The Regional Director for Africa, Dr Matshidiso Moeti , said immunizing more than
26 million people is a massive undertaking .
“But this achievement will represent a huge step towards protecting people from the potentially deadly viral haemorrhagic disease not only in Nigeria but in the African region.”
Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance noted that Routine immunisation coverage remains dangerously low, as shown by the latest outbreak, which is why this campaign is so important to protect the vulnerable.
“While this campaign will save lives, we need to focus our efforts on the best long-term solution, improving routine immunisation coverage so every child is protected, preventing outbreaks from happening in the first place.”
The Federal Ministry of Health, in collaboration with WHO with support from Gavi, has trained and deployed Management Support Teams (MST). The MSTs are overseeing preparations in the run-up to the campaign and, in partnership with WHO yellow fever experts, will act as supervisors and provide technical assistance during the campaign itself.
Recall that the first phase of the yellow fever preventive mass vaccination campaign (PMVC) took place in January and February 2018 in Kwara, Kogi and Zamfara states and parts of Borno state. Approximately 8.7 million adults and children between the ages of 9 months and 45 years of ages were vaccinated. A total of 39.9 million people are expected to be vaccinated against yellow fever this year.
The campaign is taking place as Nigeria experiences a yellow fever outbreak. Since its start in September 2017, confirmed cases have been recorded in 27 Local Government Areas across 14 states.
Nigeria is one of 50 partners pursuing the Eliminate Yellow Fever Epidemics (EYE) strategy. Steered by WHO, Gavi and UNICEF, the strategy seeks to protect at-risk populations, prevent international spread and contain outbreaks rapidly.
As part of EYE, Nigeria has developed a 10-year strategic elimination plan to reduce the incidence of yellow fever epidemics and to vaccinate at least 80% of the target population in all states by 2026.
Routine yellow fever immunization coverage in Nigeria remains extremely low. In 2016, the national routine immunization coverage (NICS) for yellow fever for children between 12 and 23 months was 39%.
Large epidemics of yellow fever occur when infected people introduce the virus into heavily populated areas with high mosquito density and low vaccination coverage. A confirmed case of yellow fever in an unvaccinated population is a potential epidemic threat.
Gavi’s support for the campaign is part of its wider commitment to boosting Nigeria’s low immunisation coverage. In return for a commitment from the Nigerian government to invest $2 billion of its own money into its vaccine programmes over the next ten years as well as a detailed accountability framework, Gavi has committed to continue supporting the country until 2028, protecting millions of children against some of the world’s deadliest diseases and helping Nigeria to save more than a million lives.